Products

Programmatic Audio

Available for: Audio, Podcasts

For over ten years, NPR has brought brands the best in podcast sponsorship — from chart topping titles and programming to innovative products and best in class measurement and attribution capabilities. Now, NPR podcast inventory is available programmatically – via private marketplace (PMP) and programmatic guaranteed deals – offering sponsors direct access to NPR’s brand-safe podcast content. 

Set Up A Deal

Specs

SSP

AudioMax

Compatible DSPs
  • AudioMatic
  • Active Agent*
  • Adelphic*
  • AdForm (USD prices only)
  • Adobe
  • Amobee*
  • Appnexus/Xandr*
  • Centro (USD prices only)*
  • ClearRTB (USD prices only)*
  • DAX*
  • NEW! DeepIntent (Supports 1st price, 2nd price and fixed price in USD only. Markets: US)*
  • Google DV360
  • Martin*
  • MediaMath
  • NEW! PayTunes (Supports 1st price in USD only | Markets: APAC/India)*
  • NEW! PulsePoint (USD prices only)*
  • NEW! Roku/One View (Supports 1st price, 2nd price, and fixed price in USD only | Markets: US and Europe)*
  • RTBIQ*
  • TabMo/Hawk (USD prices only)
  • Targetspot*
  • TheTradeDesk
  • TubeMogul*
  • Unruly/Tremor (USD prices only) *
  • Verizon Media/OATH 
Deal Options
  • Programmatic Guaranteed/Reserved
  • Private Auction (PMP)
Available Content
  • Podcasts by Genre here, along with media kit and copy guidelines here
  • Specialized package options: 
    • Run of Network – All NPR Podcasts
    • Run of Business & Innovation
    • Run of Arts & Life 
Available Inventory
  • :15s Pre-roll, Midroll, Post-roll
  • :30s Midroll 
    • Host-read option available on applicable podcasts – see rate card
Available Targeting

Behavioral, Audience, Demographic, Device

Floor Rates

Available upon request

Creative Messaging
  • Copy Guidelines 
  • Creative approval process: non-commercial creative guidelines apply. Programmatic audio copy will be vetted by NPR against our creative guidelines and voiced by NPR 
  • Blocked categories: cigarettes/e-cigarette, marijuana, gambling and other products subject to abuse; political candidacy, prescription drug products, FDA regulated devices, devices with unsubstantiated claims